Home
Biomarin Pharmaceutical BMRN spent $180K on lobbying in Q2 2024 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $180,000
- Quarter
- Q2 2024
- Client
- Biomarin Pharmaceutical
- Reported
- 24/07/22
Down 56.1% from last quarter
What else happened in Biomarin Pharmaceutical around then
Filed or reported within 30 days of the trade day · 24/05/31~24/07/30Biomarin Pharmaceutical's other lobbying reports
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$340K
$340K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 07/20
for Q2
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$30K
$30K
Reported 07/06
for Q2 2017
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$530K
$530K
Reported 04/20
for Q1
- Biomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
LobbyingBiomarin Pharmaceutical
BMRN
$50K
$50K
Reported 04/20
for Q1